Cardlytics (NASDAQ:CDLX – Get Free Report) will likely be posting its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of ($2.30) per share and revenue of $37.0030 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.
Cardlytics Price Performance
CDLX opened at $3.84 on Wednesday. The business has a 50 day moving average price of $5.15 and a two-hundred day moving average price of $7.87. The company has a market capitalization of $22.31 million, a price-to-earnings ratio of -0.22 and a beta of 0.61. Cardlytics has a 1-year low of $3.50 and a 1-year high of $32.80.
Analysts Set New Price Targets
CDLX has been the topic of a number of research reports. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, June 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, June 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, July 8th. Finally, Lake Street Capital set a $10.00 price target on shares of Cardlytics in a research report on Friday, May 8th. Two equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $10.00.
Insider Buying and Selling
In related news, CFO David Thomas Evans purchased 5,000 shares of the company’s stock in a transaction on Monday, May 18th. The shares were bought at an average price of $6.30 per share, with a total value of $31,500.00. Following the completion of the acquisition, the chief financial officer owned 31,793 shares of the company’s stock, valued at approximately $200,295.90. This represents a 18.66% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Amit Gupta sold 9,640 shares of the stock in a transaction on Monday, July 6th. The shares were sold at an average price of $4.39, for a total value of $42,319.60. Following the sale, the chief executive officer owned 113,850 shares of the company’s stock, valued at $499,801.50. This trade represents a 7.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 18,289 shares of company stock valued at $80,289 over the last 90 days. 5.90% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Cardlytics
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Qube Research & Technologies Ltd purchased a new stake in shares of Cardlytics during the third quarter valued at $55,000. Boothbay Fund Management LLC purchased a new position in Cardlytics in the 3rd quarter worth about $74,000. Virtu Financial LLC acquired a new stake in Cardlytics during the 4th quarter worth about $39,000. Marshall Wace LLP purchased a new stake in Cardlytics during the second quarter valued at about $59,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Cardlytics during the third quarter valued at about $89,000. 68.10% of the stock is owned by institutional investors and hedge funds.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Further Reading
- Five stocks we like better than Cardlytics
- D-Wave’s AT&T Deal Shows Quantum Computing Is Moving Beyond Theory
- Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
